Skip to Content

Carisoprodol Pregnancy and Breastfeeding Warnings

Carisoprodol is also known as: Soma, Vanadom

Carisoprodol Pregnancy Warnings

Animal studies have reported reduced testes weight and sperm motility. The significance of these findings for human fertility is unknown.

Carisoprodol has been assigned to pregnancy category C by the FDA. Animal studies have reported that carisoprodol crosses the placenta and results in adverse effects on fetal growth and postnatal survival. However, animal studies have not adequately evaluated the teratogenic effects of carisoprodol. There are no controlled data in human pregnancy. Carisoprodol should only be given during pregnancy when benefit outweighs risk.

See references

Carisoprodol Breastfeeding Warnings

Carisoprodol is excreted into human milk in concentrations two to four times that in the maternal plasma. Adverse effects in nursing infants have not been reported but are theoretically possible. Caution is recommended if carisoprodol is administered to a nursing woman.

In one case report, a breast-fed infant received about 4% to 6% of the maternal daily dose through breast milk and experienced no adverse effects. However, milk production was inadequate and the baby was supplemented with formula. In animal lactation studies, female offspring survival and offspring weight at weaning were decreased. This suggests that maternal use of carisoprodol may lead to reduced or less effective infant feeding (due to sedation) and/or decreased milk production.

See references

References for pregnancy information

  1. "Product Information. Soma (carisoprodol)." Wallace Laboratories, Cranbury, NJ.
  2. "Product Information. Soma Compound (aspirin-carisoprodol)." Wallace Laboratories, Cranbury, NJ.

References for breastfeeding information

  1. "Product Information. Soma Compound with Codeine (ASA/carisoprodol/codeine)." MedPointe Healthcare Inc, Somerset, NJ.
  2. "Product Information. Soma Compound (aspirin-carisoprodol)." Wallace Laboratories, Cranbury, NJ.
  3. Nordeng H, Zahlsen K, Spigset O "Transfer of carisoprodol to breast milk." Ther Drug Monit 23 (2001): 298-300
  4. "Product Information. Soma (carisoprodol)." Wallace Laboratories, Cranbury, NJ.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.